Your browser doesn't support javascript.
loading
Recent Advancements in CT and MR Imaging of Prostate Cancer.
Daryanani, Asha; Turkbey, Baris.
Afiliación
  • Daryanani A; Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, MD.
  • Turkbey B; Molecular Imaging Branch, National Cancer Institute, NIH, Bethesda, MD. Electronic address: turkbeyi@mail.nih.gov.
Semin Nucl Med ; 52(3): 365-373, 2022 05.
Article en En | MEDLINE | ID: mdl-34930627
CT and MRI are both commonly used in prostate cancer (PCa) management, which includes a large spectrum from screening positive pre-diagnosis phase to metastatic disease. CT and MRI have continually evolved to meet the changing demands for PCa management. For CT, novel techniques such as dual energy CT and photon counting CT show promising results for tissue characterization and quantification. For MRI, the detection, staging, and management of prostate cancer has been significantly improved by the development of multiparametric, biparametric, and whole-body MRI techniques. Additionally, research on ultrasmall superparamagnetic particles of iron oxide contrast-enhanced MRI has revealed promising results for nodal staging of PCa. In this manuscript we aim to outline the current status and recent advancements of CT and MRI in PCa imaging.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Límite: Humans / Male Idioma: En Revista: Semin Nucl Med Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Límite: Humans / Male Idioma: En Revista: Semin Nucl Med Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos